We use cookies to give you the best possible service. You can choose which cookies you would like us to set. Please note that depending on your settings, not all features of the page may be available. Further information can be found in our privacy policy.

Cookies we use

Here you can manage your cookie settings.


black.t Analytics

Google Analytics

This is how you manage cookies

Deleting / revoking cookies
You can manage cookies under the privacy policy at any time and revoke your selection.

Administration of site-specific cookies
If you want to know which site-specific cookies have been stored, check the privacy and cookie settings of your preferred browser.

Block cookies
In most modern browsers, you can set that no cookies should be stored on your device. The downside is that you have to make manual settings every time you visit a website again. Some services and features may not work properly then (eg log in with your profile).

Accept Decline

Development Support


Specification of IASON Services

Professional and proven scientific advice from the initial development of a drug to the submission of a marketing-authorisation application and the post-authorisation phase.




Receive tailormade advice on the pros and cons of available options with special attention to current standards, regulations, and guidelines.


New Technology Assessment

IASON also identifies potential collaboration partners for strengthening your portfolio, understands and assesses technology platforms, and also assesses the suitability of a novel technology on your behalf.


Guidelines and guidance documents provide a good initial overview on drug and device development. Due to their generic nature, however, they rarely apply to real life product development plans. IASON consulting is happy to step in and assists you with proven advice where official documentation has left gaps. 



Receive detailed feedback on your clinical development and scientific strategies as well as advice on which studies are necessary for small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), antibody therapeutics or next generation biopharmaceuticals, vaccines, antiallergics, oncolytic viruses, biosimilars, homeopathic remedies, or herbal medicines.




Getting The Most Out of Scientific Advice


Scientific advice is prospective in nature, focusing on development strategies rather than pre-evaluation of data to support a marketing-authorisation application. It helps to integrate cost-effectiveness considerations into your evidence generation plans.